Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2017-10-09
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
presymptomatic
blood sample
blood sample for metabolome analyse
symptomatic
blood sample
blood sample for metabolome analyse
controls
blood sample
blood sample for metabolome analyse
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sample
blood sample for metabolome analyse
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 20 and 70 years
* signature of the informed consent
* covered by social security
For presymptomatic group:
* positive genetic test with CAG repeat length ≥ 37 in HTT gene
* Unified Huntington Disease Rating Scale ≤ 5
For symptomatic group:
* positive genetic test with CAG repeat length ≥ 37 in HTT gene
* The Unified Huntington's Disease Rating Scale motor score ≥ 6
* The Total Functional Capacity score ≥ 11
Exclusion Criteria
* pregnancy and breastfeeding
* persons deprived of their liberty by judicial or administrative decision
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe Verny, PU-PH
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Angers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Angers
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
VERNY
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
49RC17_0086
Identifier Type: -
Identifier Source: org_study_id